These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36949799)

  • 21. Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.
    Ross CA; Pantelyat A; Kogan J; Brandt J
    Mov Disord; 2014 Sep; 29(11):1351-8. PubMed ID: 25216368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical predictors of driving status in Huntington's disease.
    Beglinger LJ; Prest L; Mills JA; Paulsen JS; Smith MM; Gonzalez-Alegre P; Rowe KC; Nopoulos P; Uc EY
    Mov Disord; 2012 Aug; 27(9):1146-52. PubMed ID: 22744778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia.
    Agostino R; Berardelli A; Formica A; Accornero N; Manfredi M
    Brain; 1992 Oct; 115 ( Pt 5)():1481-95. PubMed ID: 1422799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.
    Jahanshahi M; Brown RG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1169-77. PubMed ID: 8229028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire.
    Suzuki K; Miyamoto T; Miyamoto M; Watanabe Y; Suzuki S; Tatsumoto M; Iwanami M; Sada T; Kadowaki T; Numao A; Hashimoto K; Sakuta H; Hirata K
    BMC Neurol; 2013 Feb; 13():18. PubMed ID: 23394437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in Parkinson's disease and other movement disorders.
    Smith KM; Dahodwala N
    Exp Neurol; 2014 Sep; 259():44-56. PubMed ID: 24681088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders.
    Lim K; See YM; Lee J
    Clin Psychopharmacol Neurosci; 2017 Nov; 15(4):301-312. PubMed ID: 29073741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
    Goldman JG; Stebbins GT; Leung V; Tilley BC; Goetz CG
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1135-9. PubMed ID: 25150770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Self-awareness of deficits in Huntington's and Parkinson's disease].
    Sitek EJ; Sławek J; Wieczorek D
    Psychiatr Pol; 2008; 42(3):393-403. PubMed ID: 19899567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rating scales for cognition in Huntington's disease: Critique and recommendations.
    Mestre TA; Bachoud-Lévi AC; Marinus J; Stout JC; Paulsen JS; Como P; Duff K; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2018 Feb; 33(2):187-195. PubMed ID: 29278291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of transcranial magnetic stimulation as a treatment for movement disorders: A critical review.
    Latorre A; Rocchi L; Berardelli A; Bhatia KP; Rothwell JC
    Mov Disord; 2019 Jun; 34(6):769-782. PubMed ID: 31034682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction to the Special Issue on Clinical Neuropsychology of Movement Disorders.
    Tröster AI
    Arch Clin Neuropsychol; 2017 Nov; 32(7):767-768. PubMed ID: 29077801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson's and Huntington's disease.
    Poletti B; Solca F; Maffi S; Torre S; Carelli L; Aiello EN; Ferrucci R; Priori A; Monti A; Verde F; Ticozzi N; Migliore S; Scaricamazza E; Casella M; Squitieri F; Ciammola A; Silani V
    Front Aging Neurosci; 2022; 14():1031908. PubMed ID: 36408105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep brain stimulation for the treatment of hyperkinetic movement disorders.
    di Biase L; Munhoz RP
    Expert Rev Neurother; 2016 Sep; 16(9):1067-78. PubMed ID: 27254274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simon effect and attention in Parkinson's disease: a comparison with Huntington's disease and Tourette's syndrome.
    Cope MT; Georgiou N; Bradshaw JL; Iansek R; Phillips JG
    J Clin Exp Neuropsychol; 1996 Apr; 18(2):276-90. PubMed ID: 8780962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?
    Moscovich M; Heinzel S; Postuma RB; Reilmann R; Klockgether T; Jacobi H; Höglinger G; Berg D
    Parkinsonism Relat Disord; 2020 Dec; 81():213-218. PubMed ID: 33039276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mirror movements in movement disorders: a review.
    Cox BC; Cincotta M; Espay AJ
    Tremor Other Hyperkinet Mov (N Y); 2012; 2():. PubMed ID: 23440079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing an evidence-base framework for driving rehabilitation in Parkinson's disease: A systematic review of on-road driving studies.
    Devos H; Ranchet M; Emmanuel Akinwuntan A; Uc EY
    NeuroRehabilitation; 2015; 37(1):35-52. PubMed ID: 26409692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2.
    García-Ramos R; Santos-García D; Alonso-Cánovas A; Álvarez-Sauco M; Ares B; Ávila A; Caballol N; Carrillo F; Escamilla Sevilla F; Freire E; Gómez Esteban JC; Legarda I; López Manzanares L; López Valdés E; Martínez-Torres I; Mata M; Pareés I; Pascual-Sedano B; Martínez Castrillo JC; Mir P
    Neurologia (Engl Ed); 2021 Mar; 36(2):159-168. PubMed ID: 32980194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine therapy for Parkinson's disease and other movement disorders.
    Pfeiffer C; Wagner ML
    Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.